Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVH
1901
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $3.72M | ﹤0.01% |
572,700
-26,148
| -4% | -$185K |
|
|
TPCO
1902
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $3.72M | ﹤0.01% |
288,500
+41,400
| +17% | +$536K |
|
|
CUK
1903
DELISTED
Carnival PLC
CUK
| $3.71M | ﹤0.01% |
+56,100
| New | +$3.49M |
|
1904
DXP Enterprises
DXPE
$3.12B
| $3.71M | ﹤0.01% |
107,400
+55,100
| +105% | +$2M |
|
1905
Ampco-Pittsburgh
AP
$194M
| $3.69M | ﹤0.01% |
250,500
-800
| -0.3% | -$12K |
|
1906
BRC Group Holdings
RILY
$299M
| $3.69M | ﹤0.01% |
199,122
+168,213
| +544% | +$2.57M |
|
1907
RCM Technologies
RCMT
$248M
| $3.68M | ﹤0.01% |
728,200
-19,700
| -3% | -$99.7K |
|
|
PRSU
1908
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $3.67M | ﹤0.01% |
77,700
-67,100
| -46% | -$3M |
|
1909
CarParts.com
PRTS
$47.1M
| $3.67M | ﹤0.01% |
113,590
+17,970
| +19% | +$606K |
|
|
AY
1910
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $3.67M | ﹤0.01% |
171,700
+45,800
| +36% | +$942K |
|
1911
KVH Industries
KVHI
$145M
| $3.65M | ﹤0.01% |
384,200
-6,700
| -2% | -$59.6K |
|
|
COUP
1912
DELISTED
Coupa Software Incorporated
COUP
| $3.64M | ﹤0.01% |
+125,500
| New | +$3.8M |
|
|
DALN
1913
DELISTED
DallasNews
DALN
| $3.62M | ﹤0.01% |
164,686
-2,898
| -2% | -$66.6K |
|
|
TNAV
1914
DELISTED
Telenav Inc.
TNAV
| $3.62M | ﹤0.01% |
447,200
-1,100
| -0.2% | -$9.34K |
|
|
APTI
1915
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $3.62M | ﹤0.01% |
208,600
+127,269
| +156% | +$1.87M |
|
|
GRP.U
1916
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3.62M | ﹤0.01% |
90,800
-141,800
| -61% | -$5.32M |
|
1917
Unisys
UIS
$209M
| $3.61M | ﹤0.01% |
281,790
-332,100
| -54% | -$4.04M |
|
1918
Team
TISI
$101M
| $3.6M | ﹤0.01% |
+15,371
| New | +$3.95M |
|
1919
Allot
ALLT
$383M
| $3.6M | ﹤0.01% |
705,100
+24,000
| +4% | +$117K |
|
|
GTS
1920
DELISTED
Triple-S Management Corporation
GTS
| $3.6M | ﹤0.01% |
223,958
+80,587
| +56% | +$1.32M |
|
1921
Wabash National
WNC
$512M
| $3.6M | ﹤0.01% |
163,700
-76,300
| -32% | -$1.61M |
|
1922
Stantec
STN
$8.41B
| $3.59M | ﹤0.01% |
143,200
-143,597
| -50% | -$3.53M |
|
|
IIJI
1923
DELISTED
Internet Initiative Japan Inc
IIJI
| $3.59M | ﹤0.01% |
398,800
+200
| +0.1% | +$1.84K |
|
1924
Hope Bancorp
HOPE
$1.85B
| $3.59M | ﹤0.01% |
192,534
-46,660
| -20% | -$866K |
|
|
SHI
1925
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $3.56M | ﹤0.01% |
66,550
-21,600
| -25% | -$1.21M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.